SCHEMBL6515248

SCHEMBL6515248

CC(=CC(=O)O)CCc1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.68
▸ KEAP1 Q14145 1/20 0.55
▸ FFAR1 O14842 1/20 0.52
▸ KMT2A Q03164 1/20 0.51
▸ PDPK1 O15530 2/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ HPGD P15428 1/20 0.49
▸ HDAC2 Q92769 2/20 0.48
▸ HDAC8 Q9BY41 2/20 0.48
▸ HDAC6 Q9UBN7 2/20 0.48
▸ TDP1 Q9NUW8 2/20 0.48
▸ KDM4E B2RXH2 1/20 0.47
▸ RECQL P46063 1/20 0.47
▸ GPR52 Q9Y2T5 1/20 0.47
▸ HDAC1 Q13547 2/20 0.47
▸ HDAC3 O15379 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ ADRA1A P35348 1/20 0.47
▸ HDAC4 P56524 1/20 0.47
▸ SLC6A3 Q01959 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6521611 1.00 ALDH1A1 (0.68) ALDH1A1KEAP1FFAR1KMT2APDPK1
SCHEMBL6515245 1.00 ALDH1A1 (0.68) ALDH1A1KEAP1FFAR1KMT2APDPK1
SCHEMBL12827004 0.89 HDAC1 (0.58) ALDH1A1KEAP1SMN1; SMN2HPGDHDAC2
SCHEMBL16288837 0.89 HDAC1 (0.58) ALDH1A1KEAP1SMN1; SMN2HPGDHDAC2
SCHEMBL20608254 0.89 ALDH1A1 (0.68) ALDH1A1KEAP1FFAR1KMT2ASMN1; SMN2
SCHEMBL17429280 0.87 ALDH1A1 (0.66) ALDH1A1KEAP1FFAR1KMT2ASMN1; SMN2
SCHEMBL11576206 0.82 ALDH1A1 (0.59) ALDH1A1KEAP1FFAR1SMN1; SMN2HPGD
SCHEMBL11576204 0.82 ALDH1A1 (0.59) ALDH1A1KEAP1FFAR1SMN1; SMN2HPGD
SCHEMBL8616037 0.82 PDPK1 (0.68) ALDH1A1FFAR1PDPK1SMN1; SMN2HPGD
SCHEMBL4276447 0.82 FFAR1 (0.47) ALDH1A1FFAR1KMT2APDPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12630781-B2 Fragrance or flavour mixture SYMRISE AG (DE) 2026-05-19 — — US disclosed
US-12630783-B2 Muguet type fragrance compounds SYMRISE AG (DE) 2026-05-19 — — US disclosed
US-12625123-B2 Device and method for the analytical and sensory determination of the release of an active substance from a release system SYMRISE AG (DE) 2026-05-12 — — US disclosed
EP-4192614-B1 PROCESS FOR THE PREPARATION OF MICROCAPSULES SYMRISE AG (DE) 2026-05-06 — — EP disclosed
EP-4724434-A1 AMBERGRIS ISOMERS AND MIXTURES THEREOF Symrise AG (DE) 2026-04-15 — — EP disclosed
US-12583833-B2 Enrichment of a diastereomer in Magnolan SYMRISE AG (DE) 2026-03-24 — — US disclosed
US-12577495-B2 Fragrance mixtures containing 1-(4,4-dimethylcyclohexen-1-yl) ethanon SYMRISE AG (DE) 2026-03-17 — — US disclosed
US-12552732-B2 Cyclopropanated sandalwood type compounds SYMRISE AG (DE) 2026-02-17 — — US disclosed
EP-4687810-A1 PREPARATIONS COMPRISING HYDROXY PINACOLONE RETINOATE Symrise AG (DE) 2026-02-11 — — EP disclosed
US-12545851-B2 Fragrances with note of lily of the valley SYMRISE AG (DE) 2026-02-10 — — US disclosed
WO-2022053140-A1 SURFACTANT CONTAINING FORMULATION OF PSEUDO-CERAMIDES SYMRISE AG (DE) 2022-03-17 — — WO disclosed
US-20220033338-A1 2-(5-ISOPROPYL-2-METHYL-CYCLOHEX-2-EN- 1-YL-)ACETALDEHYDE AND 2-(6-ISOPROPYL- 3-METHYL-CYCLOHEX-2-EN-1-YL-) ACETALDEHYDE AS NEW ODORANTS SYMRISE AG (DE) 2022-02-03 — — US disclosed
EP-3601510-A1 2,3,6-TRIMETHYLCYCLOHEXANOL AS A SCENTING AND/OR FLAVORING AGENT Symrise AG (DE) 2020-02-05 — — EP disclosed
CN-105228993-B Compound and its purposes as spices 西姆莱斯股份公司 2018-02-13 — — CN disclosed
US-20050065349-A1 Asymmetric 1,4-reductions of and 1,4-additions to enoates and related systems BUCHWALD STEPHEN L (US) 2005-03-24 — — US disclosed
US-6787655-B2 TRANSITION-METAL-CATALYZED ASYMMETRIC 1,4-ADDITION OF A NUCLEOPHILE, E.G., HYDRIDE, TO CYCLIC AND ACYCLIC ENOATES AND ENONES AND THE CATALYST CONTAINING A COPPER AND AN ASYMMETRIC BIDENTATE BISPHOSPHINE LIGAND MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2004-09-07 — — US disclosed
US-20030125563-A1 Asymmetric 1,4-reductions of and 1,4-additions to enoates and related systems NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-07-03 — — US disclosed
US-6465664-B1 CATALYZED WITH A TRANSITION METAL CATALYST COMPOSED OF A COPPER COMPOUND AND AN ASYMMETRIC LIGAND, SUCH AS A PHOSPHINE, A NUCLEOPHILE AND A BASE MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2002-10-15 — — US disclosed
WO-2001019761-A2 ASYMMETRIC 1,4-REDUCTIONS OF AND 1,4-ADDITIONS TO ENOATES AND RELATED SYSTEMS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2001-03-22 — — WO disclosed
US-3939274-A Phenoxyphenylalkanoic acid ester insecticides CIBA-GEIGY CORPORATION (US) 1976-02-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12583833-B2 Enrichment of a diastereomer in Magnolan TRPA1, ENO1, ADH1A ALDH1A1 4/4885KEAP1 543/4885FFAR1 3047/4885
US-12577495-B2 Fragrance mixtures containing 1-(4,4-dimethylcyclohexen-1-yl) ethanon ALG3, FAAH, FAAH2 ALDH1A1 53/4885KEAP1 2746/4885FFAR1 86/4885
US-12630783-B2 Muguet type fragrance compounds MGAT1, RFT1, CPT1A ALDH1A1 132/4885KEAP1 2846/4885FFAR1 681/4885
US-20050065349-A1 Asymmetric 1,4-reductions of and 1,4-additions to enoates and related systems APEX1, AP2A1, ENPP1 ALDH1A1 123/4885KEAP1 1026/4885FFAR1 2622/4885
US-12625123-B2 Device and method for the analytical and sensory determination of the release of an active substance from a release system TAS2R7, TAS2R42, TAS2R39 ALDH1A1 696/4885KEAP1 3772/4885FFAR1 2575/4885
US-12552732-B2 Cyclopropanated sandalwood type compounds FAAH2, ADCY10, OR10J3 ALDH1A1 8/4885KEAP1 875/4885FFAR1 406/4885
US-20220033338-A1 2-(5-ISOPROPYL-2-METHYL-CYCLOHEX-2-EN- 1-YL-)ACETALDEHYDE AND 2-(6-ISOPROPYL- 3-METHYL-CYCLOHEX-2-EN-1-YL-) ACETALDEHYDE AS NEW ODORANTS ADH5, PIR, ACLY ALDH1A1 6/4885KEAP1 1287/4885FFAR1 1176/4885
US-12545851-B2 Fragrances with note of lily of the valley TRPA1, CDY1; CDY1B, TMEM109 ALDH1A1 74/4885KEAP1 2009/4885FFAR1 1507/4885
US-20030125563-A1 Asymmetric 1,4-reductions of and 1,4-additions to enoates and related systems APEX1, AP2A1, ENPP1 ALDH1A1 123/4885KEAP1 1026/4885FFAR1 2622/4885
US-12630781-B2 Fragrance or flavour mixture NOTUM, FFAR2, FFAR1 ALDH1A1 79/4885KEAP1 2891/4885FFAR1 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback